197 related articles for article (PubMed ID: 23803604)
21. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
22. Lipid rafts are required for Kit survival and proliferation signals.
Jahn T; Leifheit E; Gooch S; Sindhu S; Weinberg K
Blood; 2007 Sep; 110(6):1739-47. PubMed ID: 17554062
[TBL] [Abstract][Full Text] [Related]
23. Differential activity of c-KIT splice forms is controlled by extracellular peptide insert length.
Phung B; Steingrímsson E; Rönnstrand L
Cell Signal; 2013 Nov; 25(11):2231-8. PubMed ID: 23880320
[TBL] [Abstract][Full Text] [Related]
24. PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
Lindblad O; Kazi JU; Rönnstrand L; Sun J
Cell Mol Life Sci; 2015 Nov; 72(22):4399-407. PubMed ID: 26040420
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
[TBL] [Abstract][Full Text] [Related]
26. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Wisniewski D; Strife A; Clarkson B
Leukemia; 1996 Sep; 10(9):1436-42. PubMed ID: 8751459
[TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.
Chian R; Young S; Danilkovitch-Miagkova A; Rönnstrand L; Leonard E; Ferrao P; Ashman L; Linnekin D
Blood; 2001 Sep; 98(5):1365-73. PubMed ID: 11520784
[TBL] [Abstract][Full Text] [Related]
28. The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.
Yu M; Luo J; Yang W; Wang Y; Mizuki M; Kanakura Y; Besmer P; Neel BG; Gu H
J Biol Chem; 2006 Sep; 281(39):28615-26. PubMed ID: 16873377
[TBL] [Abstract][Full Text] [Related]
29. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.
Tsujimura T; Hashimoto K; Kitayama H; Ikeda H; Sugahara H; Matsumura I; Kaisho T; Terada N; Kitamura Y; Kanakura Y
Blood; 1999 Feb; 93(4):1319-29. PubMed ID: 9949175
[TBL] [Abstract][Full Text] [Related]
30. Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells.
Young SM; Cambareri AC; Ashman LK
Cell Signal; 2006 May; 18(5):608-20. PubMed ID: 16002264
[TBL] [Abstract][Full Text] [Related]
31. BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia.
Chen LT; Chen CT; Jiaang WT; Chen TY; Butterfield JH; Shih NY; Hsu JT; Lin HY; Lin SF; Tsai HJ
Mol Cancer Ther; 2016 Oct; 15(10):2323-2333. PubMed ID: 27512117
[TBL] [Abstract][Full Text] [Related]
32. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
Sattler M; Salgia R; Shrikhande G; Verma S; Pisick E; Prasad KV; Griffin JD
J Biol Chem; 1997 Apr; 272(15):10248-53. PubMed ID: 9092574
[TBL] [Abstract][Full Text] [Related]
33. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
Zhu QS; Robinson LJ; Roginskaya V; Corey SJ
Blood; 2004 May; 103(9):3305-12. PubMed ID: 14656892
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.
Chaix A; Lopez S; Voisset E; Gros L; Dubreuil P; De Sepulveda P
J Biol Chem; 2011 Feb; 286(8):5956-66. PubMed ID: 21135090
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of activation of human c-KIT kinase by internal tandem duplications of the juxtamembrane domain and point mutations at aspartic acid 816.
Kim SY; Kang JJ; Lee HH; Kang JJ; Kim B; Kim CG; Park TK; Kang H
Biochem Biophys Res Commun; 2011 Jul; 410(2):224-8. PubMed ID: 21640708
[TBL] [Abstract][Full Text] [Related]
36. The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia.
Larizza L; Magnani I; Beghini A
Leuk Lymphoma; 2005 Feb; 46(2):247-55. PubMed ID: 15621809
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.
Lennartsson J; Blume-Jensen P; Hermanson M; Pontén E; Carlberg M; Rönnstrand L
Oncogene; 1999 Sep; 18(40):5546-53. PubMed ID: 10523831
[TBL] [Abstract][Full Text] [Related]
38. Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.
Wardega P; Heldin CH; Lennartsson J
Cell Signal; 2010 Sep; 22(9):1363-8. PubMed ID: 20494825
[TBL] [Abstract][Full Text] [Related]
39. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
Leahy M; Lyons A; Krause D; O'Connor R
J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
[TBL] [Abstract][Full Text] [Related]
40. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
